Gilead Sciences Inc

About

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.

Key Statistics

Market Cap

156.28B

Price-Earnings ratio

17.13

Earnings-Per-Share

$7.35

52 Week Range

$102.48 - $156.40

Beta

0.33

Dividend Yield

2.63%

Analyst Ratings

77% Buy
of 31 ratings

Corporate Intelligence

Structured metrics extracted from SEC filings — KPIs, guidance, governance, compensation, and legal disclosures.

Retrieving structured corporate metrics...

Research Documents

Browse SEC filings and earnings transcripts.

Ticker

Type

Filing Type

Year

Quarter

AI Research

Analyze latest 10-K

View Financial Data

Start AI Chat

Pages